Wilms tumor, AML and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia

Pediatric Blood and Cancer

Volumn 53, Issue 2, 2009, Pages 208-210

  Sari, Neriman ^a   Akyuz, Canan ^b   Aktas, Dilek ^b   Gumruk, Fatma ^b   Orhan, Diclehan ^b   Alikasifoglu, Mehmet ^b   Aydin, Burca ^a   Alanay, Yasemin ^b   Buyukpamukcu, Munevver ^b  

^a ANKARA ONCOLOGY HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

AML; Fanconi anemia; Medulloblastoma; Total premature chromatid separation; Wilms tumor

Indexed keywords

DACTINOMYCIN; HEMOGLOBIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLOOD SMEAR; BONE MARROW EXAMINATION; CAFE AU LAIT SPOT; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CHILD; CHILDHOOD DISEASE; CHROMATID; CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; DISEASE ASSOCIATION; DISEASE SEVERITY; FANCONI ANEMIA; FEMALE; FLOW CYTOMETRY; GROWTH RETARDATION; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; LEUKOCYTOSIS; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEPHROURETERECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPSIS; SPINAL CORD METASTASIS; TUMOR VOLUME; VOMITING; CEREBELLUM TUMOR; DISORDERS OF DNA SYNTHESIS AND REPAIR; INFANT; MULTIPLE MALFORMATION SYNDROME; PATHOLOGY;

ABNORMALITIES, MULTIPLE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; DNA REPAIR-DEFICIENCY DISORDERS; FANCONI ANEMIA; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID, ACUTE; MEDULLOBLASTOMA; WILMS TUMOR;

EID: 67649986712     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21966     Document Type: Article

References (17)

1. Dome JS, Ritchey ML, Kalapurakal J, et al. Renal tumors. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. Philadelphia: Lippincott Williams and Wilkins; 2006. pp. 905-932.
2. Alter PB. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski's hematology of infancy and childhood, 6th edition. Philadelphia: WB Saunders Company, an imprint of Elsevier, Inc.; 2003. pp. 280-365.
3. Tischkowitz M, Dokal I. Fanconi anemia and leukaemia-clinical and molecular aspects. Br J Hematol 2004;126:176-191. (Pubitemid 38961936)
4. Kajii T, Kawai T, Takumi T, et al. Mosaic variegated aneuploidy with multiple congenital abnormalities: Homozygosity for total premature chromatid separation trait. Am J Med Genet 1998;78:245-249. (Pubitemid 28307538)
5. Kawame H, Sugio Y, Fuyama Y, et al. Syndrome of microcephaly, Dandy-Walker malformation andWilms' tumor caused by mosaic variegated aneuploidy and premature centromere division (PCD): Report of a new case and review of the literature. J Hum Genet 1999;44:219-224. (Pubitemid 29313978)
6. Kajii T, Ikeuchi T, Yang ZQ, et al. Cancer-prone syndrome of mosaic variegated aneuploidy and total premature chromatid separation: Report of five infants. Am J Med Genet 2001; 104:57-64.
7. Plaja A, Vendrell T, Smeets D, et al. Variegated aneuploidy related to premature centromere division (PCD) is expressed in vivo and is a cancer-prone disease. Am J Med Genet 2001;98:216-223. (Pubitemid 32118984)
8. Matsuura S, Ito E, Tauchi H, et al. Chromosomal instability syndrome of total premature chromatid separation with mosaic variegated aneuploidy is defective in mitotic-spindle checkpoint. Am J Hum Genet 2000;67:483-486. (Pubitemid 30616749)
9. Furukawa T, Azakami S, Kurosawa H, et al. Cystic partially differentiated nephroblastoma, embriyonal rhabdomyosarcoma and multiple congenital anomalies associated with mosaic variegated aneuploidy and premature centromere division: A case report. J Pediatr Hematol Oncol 2003;25:896-899. (Pubitemid 37413841)
10. Mehes K, Kajtar P, Kosztolanyi G. Assosiation of nonsyndromic Wilms' tumor with premature centromere division (PCD). Am J Med Genet 2002;112:215-216. (Pubitemid 35332190)
11. Auerbach AD, Rogatko A, Schroeder-Kurth T. International Fanconi Anemia Registry: Relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989;73:391-396.
12. Auerbach AD, Ghosh R, Pollio PC, et al. Diepoxybutane (DEB) test for prenatal and postnatal diagnosis of Fanconi anemia. In: Schroeder TM, Auerbach AD, Obe G, editors. Fanconi anemia, clinical, cytogenetic and experimental aspects, Heidelberg: Springer-Verlag; 1989. pp. 71-82.
13. Hiçsönmez G. The effect of steroid on myeloid leukemic cells: The potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leuk Res 2006;30:60-68. (Pubitemid 41654706)
14. Amaziane N, Errami A, Leveille F, et al. Genetic subtyping of Fanconi anemia by comprehensive mutation screening. HumMutat 2008;29:159-166.
15. Reid S, Renwick A, Seal S, et al. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familialWilms tumour. J Med Genet 2005;42:147-151. (Pubitemid 40204369)
16. Chadarevian JP, Vekemans M, Berstein M. Fanconi's anemia, medulloblastoma, Wilms tumor, horseshoe kidney and gonadal dysgenesis. Arch Pathol Lab Med 1985;109:367-369. (Pubitemid 15077777)
17. Hirsch B, Shimamura A, Moreau L, et al. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 2004;103:2554-2559. (Pubitemid 38393006)